General Information of the Compound
| Compound ID |
CP0546505
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[(3S)-1-(cyclobutylamino)-1-oxo-5-piperidin-1-ylpentan-3-yl]-1-cyclopentyl-5-(2,6-dimethylphenyl)pyrazole-3-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C31H45N5O2
|
||||||||||||||||||
| Molecular Weight |
519.734
|
||||||||||||||||||
| Canonical SMILES |
Cc1cccc(C)c1-c1cc(nn1C1CCCC1)C(=O)N[C@@H](CCN1CCCCC1)CC(=O)NC1CCC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C31H45N5O2/c1-22-10-8-11-23(2)30(22)28-21-27(34-36(28)26-14-4-5-15-26)31(38)33-25(16-19-35-17-6-3-7-18-35)20-29(37)32-24-12-9-13-24/h8,10-11,21,24-26H,3-7,9,12-20H2,1-2H3,(H,32,37)(H,33,38)/t25-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
BEULUOOKZZIGIY-VWLOTQADSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound